Covestor’s Inhibrx INBX Stock Holding History

Covestor’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Buy	3 +2	+200%	+$200	﹤0.01%	2649
2026 Q1	$0	Buy	+1	New	+$74	﹤0.01%	2507
2024 Q4	–	Sell	-1,666	Closed	-$26K	–	2468
2024 Q3	$26K	Buy	+1,666	New	+$23.4K	0.02%	1121

Other funds holding INBX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Covestor's INBX Position: Q2 2026 in Review

Covestor increased its Inhibrx (INBX) stake by 200% in Q2 2026, buying an estimated $200 and bringing the position to 3 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2649.

Covestor first reported a position in INBX in Q3 2024 and has held it in 3 quarters since. The position peaked at $26K in Q3 2024. 162 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

Covestor held 3 shares of Inhibrx worth $0 as of Q2 2026.
Covestor bought 2 Inhibrx shares in Q2 2026, an estimated $200.
Inhibrx made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2649 holding.
Covestor first reported a position in Inhibrx in Q3 2024 and has held it in 3 quarters since.
Covestor's Inhibrx position peaked at $26K in Q3 2024.
162 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.